Direktorat Registrasi ObatValid

CEFTAZIDIME PENTAHYDRATE

BPOM Number: GKL0208505244A1
Approved: 21 November 2024
Expiry: 12 January 2023
Form: SERBUK INJEKSI; 1 G/VIAL

About This Registration

CEFTAZIDIME PENTAHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0208505244A1. Its current registration status is Valid, with the licence valid until 12 January 2023. The product is registered to HEXPHARM JAYA LABORATORIES - INDONESIA. BPOM first approved this registration in January 2018. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 2 VIAL @ 1 G
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

HEXPHARM JAYA LABORATORIES - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

HEXPHARM JAYA LABORATORIES - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

CEFTAZIDIME

Market Intelligence

Owner Portfolio: HEXPHARM JAYA LABORATORIES - INDONESIA holds 155 BPOM registrations
Manufacturer Scale: HEXPHARM JAYA LABORATORIES - INDONESIA produces 155 registered products
Registration Age: Registered for 8 years, 8 months
Expiry Status: Expired 1353 days ago

FDA Cross-Reference

via openFDA

Generic Name: CEFTAZIDIME
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?